TBK1 gRNA (BRDN0001148392) Citations (1)

Originally described in: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE Nat Biotechnol. 2016 Jan 18. doi: 10.1038/nbt.3437. PubMed Journal

---

Articles Citing TBK1 gRNA (BRDN0001148392)

Articles
The master antioxidant defense is activated during EBV latent infection. Wang L, Howell MEA, Hensley CR, Ning K, Moorman JP, Yao ZQ, Ning S. J Virol. 2023 Nov 30;97(11):e0095323. doi: 10.1128/jvi.00953-23. Epub 2023 Oct 25. PubMed

If you have published an article using this material, please email us at to have your article added to this page.